Table 4. Baseline and post-treatment scores of SF-36 subscales.
| Baseline | 3rd week | 3rd month | |||||
| SF-36 | Median | 95% CI | Median | 95% CI | Median | 95% CI | p |
| PF | 30 | 29.85-39.21 | 45 | 40.79-50.53 | 40 | 29.93-47.35 | 0.021* |
| SF | 50 | 48.81-59.52 | 62,5 | 56.02-67.4 | 62,5 | 50.29-64.29 | 0.036* |
| PR | 0 | 8.8-21.2 | 13,63 | 22.34-40.99 | 0 | 16.19-45.93 | 0,163 |
| ER | 33,33 | 20.61-34.5 | 33,33 | 32.15-50.24 | 33,33 | 27.57-57.28 | 0,061 |
| MH | 52 | 48.78-57.46 | 60 | 52.68-62.73 | 56 | 43.5-49.05 | 0,158 |
| VT | 40 | 36.83-46.5 | 50 | 41.62-52.05 | 40 | 36.54-53.46 | 0,066 |
| BP | 30 | 24.52-33.56 | 45 | 45.12-56.21 | 45 | 35.14-52.74 | 0.002* |
| GH | 35 | 31.37-40.76 | 40 | 36.94-46.96 | 45 | 34.9-50.86 | 0,485 |
| SF-36: Short Form 36; CI: Confidence interval; PF: Physical functioning; SF: Social functioning; PR: Physical role functioning; ER: Emotional role functioning; MH: Mental health; VT: Vitality; BP: Bodily pain; GH: General health; * p<0.05 statistically significant; Friedman’s test was applied. | |||||||